title: Epstein-Barr virus (EBV). VI. Incidence of EBV antibodies in patients with malignant lymphoproliferative diseases.
abstract: Serum samples from 52 patients with malignant lymphoproliferative diseases and 12 clinically healthy subjects were tested by indirect immunofluorescence (IF) reaction for the presence of specific EB antibodies anti-VCA and active EBV infection. The tests revealed EB antibodies anti-VCA in 32 patients with lymphoproliferative diseases and in 2 clinically healthy subjects and active EBV infection in 18/32 and in 0/2 EB anti-VCA positive patients and clinically healthy subjects, respectively.
authors.affiliation: Stefan S. Nicolau Institute of Virology, Bucharest, Romania.
authors.forename: I V
authors.initials: IV
authors.lastname: Pătraşcu
authors.forename: M
authors.initials: M
authors.lastname: Tache
authors.forename: R
authors.initials: R
authors.lastname: Stoia
authors.forename: S
authors.initials: S
authors.lastname: Berceanu
mesh_terms: D000914:Antibodies, Viral / Q000032:analysis*; D000918:Antibody Specificity; D002213:Capsid / Q000276:immunology; D005455:Fluorescent Antibody Technique; D006566:Herpesviridae Infections / Q000276:immunology; D004854:Herpesvirus 4, Human / Q000276:immunology*; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D008232:Lymphoproliferative Disorders / Q000276:immunology*
chemical_list: D000914:Antibodies, Viral; D007074:Immunoglobulin G; D007075:Immunoglobulin M